Group One Trading
RNAC icon

Group One Trading’s Cartesian Therapeutics RNAC Stock Holding History

Group One Trading’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-94
Closed -$2.24K – 7374
2024
Q1 		$1.84K Sell
94
-14
-13% -$297 ﹤0.01% 6506
2023
Q4 		$2.23K Sell
108
-33
-23% -$985 ﹤0.01% 6789
2023
Q3 		$4.49K Sell
141
-70
-33% -$2.34K ﹤0.01% 6744
2023
Q2 		$7.1K Sell
211
-301
-59% -$10.8K ﹤0.01% 6562
2023
Q1 		$21.3K Buy
+512
New +$24.1K ﹤0.01% 5460
2022
Q4 		– Sell
-1,464
Closed -$72K – 7968
2022
Q3 		$72K Sell
1,464
-1,339
-48% -$73.5K ﹤0.01% 5092
2022
Q2 		$110K Buy
2,803
+369
+15% +$10.9K ﹤0.01% 4902
2022
Q1 		$90K Buy
2,434
+573
+31% +$35.8K ﹤0.01% 5591
2021
Q4 		$182K Buy
+1,861
New +$200K ﹤0.01% 5183
2021
Q3 		– Sell
-2,773
Closed -$335K – 8703
2021
Q2 		$348K Buy
2,773
+1,727
+165% +$206K ﹤0.01% 4622
2021
Q1 		$142K Buy
1,046
+582
+125% +$72.3K ﹤0.01% 5333
2020
Q4 		$42K Sell
464
-131
-22% -$11.4K ﹤0.01% 5123
2020
Q3 		$44K Sell
595
-1,176
-66% -$90.1K ﹤0.01% 4717
2020
Q2 		$151K Buy
1,771
+428
+32% +$38.8K ﹤0.01% 3606
2020
Q1 		$97K Buy
+1,343
New +$130K ﹤0.01% 3323
2019
Q3 		– Sell
-125
Closed -$7K – 5471
2019
Q2 		$7K Hold
125
– – ﹤0.01% 4524
2019
Q1 		$9K Buy
125
+72
+136% +$4.56K ﹤0.01% 4315
2018
Q4 		$4K Buy
53
+40
+308% +$9.13K ﹤0.01% 4531
2018
Q3 		$6K Buy
+13
New +$5.22K ﹤0.01% 4792

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's RNAC Position: Q2 2024 in Review

Group One Trading sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 94 shares — an estimated $2.24K sold.

Group One Trading first reported a position in RNAC in Q3 2018 and held it in 19 quarters. The position peaked at $348K in Q2 2021. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • Group One Trading reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 94 Cartesian Therapeutics shares in Q2 2024, an estimated $2.24K.
  • Group One Trading first reported a position in Cartesian Therapeutics in Q3 2018 and held it in 19 quarters.
  • Group One Trading's Cartesian Therapeutics position peaked at $348K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.